SecBot SecBot
SECBOTREPLAY Home › Report › VERA

VERA · Five executive officers at Vera Therapeutics, including the CEO and…

Vera Therapeutics, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Five executive officers at Vera Therapeutics, including the CEO and CFO, collectively sold over $1.2 million in shares in a coordinated open-market transaction on February 23, 2026. All sales occurred at the same price, indicating a planned divestment during a short trading window.

  • CEO Fordyce Marshall sold $710,578 worth of shares, the largest individual transaction.
  • All five executives sold shares on the same day at $41.9839 per share, totaling $1,184,869.626 in aggregate value.
  • Sellers include C-suite leaders across operations, finance, regulatory, and commercial functions, indicating broad insider participation.
  • Transactions were open-market sales (Form 4 'S' code), not driven by tax events or option exercises.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access